ArticleJournal of managed care & specialty pharmacy2026
State-level variation in the use of glucagon-like peptide-1 receptor agonists for weight loss and diabetes: a real-world analysis.
Steven Do et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.